FTC Solicits Public Comment On PBM Impact On Drug Affordability

By Gabrielle Wanneh / February 24, 2022 at 6:43 PM
The Federal Trade Commission is requesting public input on how a wide range of common practices used by large, vertically integrated pharmacy benefit managers are impacting drug affordability. The RFI comes just days after FTC voted against launching an investigation to study the impact of PBM practices on drug prices and pharmacies . That investigation, which would have allowed FTC to subpoena information from companies, could have been much more aggressive than the new request for information. Key concerns the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.